Outcome measures in spinal cord injury: recent assessments and recommendations for future directions.
Outcome measures in spinal cord injury: recent assessments and recommendations for future directions.
复制标题
DOI：
10.1038/sc.2009.18
复制
发表时间：
2009-08
期刊：
影响因子：
2.2
通讯作者：
Whiteneck, G.
中科院分区：
文献类型：
--
作者：
Alexander, M. S.;Anderson, K. D.;Biering-Sorensen, F.;Blight, A. R.;Brannon, R.;Bryce, T. N.;Creasey, G.;Catz, A.;Curt, A.;Donovan, W.;Ditunno, J.;Ellaway, P.;Finnerup, N. B.;Graves, D. E.;Haynes, B. A.;Heinemann, A. W.;Jackson, A. B.;Johnston, M. V.;Kalpakjian, C. Z.;Kleitman, N.;Krassioukov, A.;Krogh, K.;Lammertse, D.;Magasi, S.;Mulcahey, M. J.;Schurch, B.;Sherwood, A.;Steeves, J. D.;Stiens, S.;Tulsky, D. S.;van Hedel, H. J. A.;Whiteneck, G.
关键词：
脊髓结果伙伴关系奋进（SCOPE）的审查，这是一个基础广泛的国际联盟的科学家和临床研究人员代表学术机构，行业，政府机构，非营利组织和基金会。评估目前和不断发展的工具，用于评估人类脊髓损伤（SCI）的临床诊断和临床研究结果。一个评估度量属性证据的框架被用来检查人类SCI的准确性、敏感性、可靠性和有效性的结果工具或测试。评估了影像学、神经学、功能、自主神经、性健康、膀胱/肠、疼痛和心理社会工具。已经或正在开发几种用于人类SCI研究的特定工具，以更准确地确定治疗干预所带来的临床有意义的益处（功能结局或生活质量的改善）。已经取得了重大进展，但需要进一步的验证研究，以确定最合适的工具，为特定的目标，在人类脊髓损伤的研究或临床试验。
review by the Spinal Cord Outcomes Partnership Endeavor (SCOPE), which is a broad-based international consortium of scientists and clinical researchers representing academic institutions, industry, government agencies, not-for-profit organizations and foundations. assessment of current and evolving tools for evaluating human spinal cord injury (SCI) outcomes for both clinical diagnosis and clinical research studies. a framework for the appraisal of evidence of metric properties was used to examine outcome tools or tests for accuracy, sensitivity, reliability and validity for human SCI. imaging, neurological, functional, autonomic, sexual health, bladder/bowel, pain, and psycho-social tools were evaluated. Several specific tools for human SCI studies have or are being developed to allow the more accurate determination for a clinically meaningful benefit (improvement in functional outcome or quality of life) being achieved as a result of a therapeutic intervention. significant progress has been made, but further validation studies are required to identify the most appropriate tools for specific targets in a human SCI study or clinical trial.
登录
查看更多内容
DOI：
10.1097/01.phm.0000233200.43822.21
发表时间：
2007-01-01
影响因子：
3
作者：
Gandek, Barbara;Sinclair, Samuel J.;Ware, John E., Jr.
通讯作者：
Ware, John E., Jr.
影响因子：
2.2
作者：
Itzkovich, M.;Gelernter, I.;Catz, A.
通讯作者：
Catz, A.
影响因子：
4.3
作者：
Andresen, EM;Lollar, DJ;Meyers, AR
通讯作者：
Meyers, AR
影响因子：
2.2
作者：
Biering-Sorensen, F.;Charlifue, S.;Wing, P.
通讯作者：
Wing, P.
DOI：
10.1097/00004356-199806000-00002
发表时间：
1998-06-01
影响因子：
1.7
作者：
Fougeyrollas, P;Noreau, L;St-Michel, G
通讯作者：
St-Michel, G